RESUMO
Acitretin, a vitamin A derivative used for psoriasis, can prevent keratinocyte carcinoma (KC). It induced regression of keratoacanthomas (KA) in animal models, presumably by activating retinoic acid and retinoid X receptors that regulate gene expression for growth and proliferation.1,2.
Assuntos
Acitretina/administração & dosagem , Carcinoma Basocelular/epidemiologia , Carcinoma de Células Escamosas/epidemiologia , Recidiva Local de Neoplasia/epidemiologia , Neoplasias Cutâneas/epidemiologia , Idoso , Idoso de 80 Anos ou mais , Carcinoma Basocelular/diagnóstico , Carcinoma Basocelular/patologia , Carcinoma Basocelular/terapia , Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/patologia , Carcinoma de Células Escamosas/terapia , Prescrições de Medicamentos/estatística & dados numéricos , Feminino , Seguimentos , Hospitais de Veteranos/estatística & dados numéricos , Humanos , Masculino , Recidiva Local de Neoplasia/diagnóstico , Recidiva Local de Neoplasia/patologia , Recidiva Local de Neoplasia/prevenção & controle , Estudos Retrospectivos , Prevenção Secundária/métodos , Pele/patologia , Neoplasias Cutâneas/diagnóstico , Neoplasias Cutâneas/patologia , Neoplasias Cutâneas/terapia , Veteranos/estatística & dados numéricosRESUMO
Topical 5-fluorouracil (5-FU) is a valuable treatment of actinic keratosis (AK), but its use is limited by bothersome side effects. To evaluate patient satisfaction with a regimen of 5-FU for AK in group clinics, we offered participation in shared medical appointments (SMAs) to dermatology clinic patients diagnosed with AK at the Providence VA Medical Center in Rhode Island. Approximately 3 to 4 patients attended each pair of sessions spaced 2 weeks apart. At each visit, photographs and feedback were obtained; at the second visit, clinicians graded the patients' reactions to 5-FU according to a validated numeric scale. Of the 14 study patients who attended the second SMA, 10 stated that they completed 2 weeks of 5-FU therapy, and the other 4 stated that they completed at least 11 days. The validated scale used during the second visit to grade the patients' 5-FU reactions confirmed that all 14 patients demonstrated at least 1 expected adverse skin reaction. Feedback about the group setting was uniformly positive, with specific appreciation for the educational aspects, normalization of the treatment process, and opportunities to ask questions. The group clinic setting for 5-FU was well received and is a promising model for delivering this important treatment.
Assuntos
Antimetabólitos Antineoplásicos/administração & dosagem , Carcinoma de Células Escamosas/prevenção & controle , Fluoruracila/administração & dosagem , Ceratose Actínica/tratamento farmacológico , Consultas Médicas Compartilhadas , Neoplasias Cutâneas/prevenção & controle , Veteranos , Administração Tópica , Idoso , Carcinoma de Células Escamosas/etiologia , Quimioprevenção/métodos , Humanos , Ceratose Actínica/complicações , Masculino , Satisfação do Paciente , Projetos Piloto , Neoplasias Cutâneas/etiologia , Resultado do Tratamento , Serviços de Saúde para Veteranos MilitaresRESUMO
Unrecognized skin conditions are highly prevalent among the elderly population.[10] Bullous pemphigoid (BP), an autoimmune dermatologic disease with greater incidence in the elderly, typically features pruritus, tense bullae formation, and negative Nikolsky's sign.[1,2] We describe a case of BP in an elderly Veteran that developed insidiously for months before it presented with a life-threatening secondary infection due to Methicillin Resistant Staphylococcus Aureus (MRSA).
Assuntos
Bacteriemia/etiologia , Celulite (Flegmão)/etiologia , Staphylococcus aureus Resistente à Meticilina/isolamento & purificação , Penfigoide Bolhoso/complicações , Idoso de 80 Anos ou mais , Celulite (Flegmão)/microbiologia , Diagnóstico Diferencial , Humanos , Masculino , Penfigoide Bolhoso/patologia , Índice de Gravidade de Doença , Pele/patologia , VeteranosAssuntos
Pacientes não Comparecentes/estatística & dados numéricos , Dermatopatias , Serviços de Saúde para Veteranos Militares/estatística & dados numéricos , Adulto , Idoso , Estudos de Coortes , Estudos Transversais , Feminino , Hospitais de Veteranos , Humanos , Masculino , Pessoa de Meia-Idade , Dermatopatias/terapia , Estados Unidos , Saúde dos Veteranos , Adulto JovemRESUMO
Background: As technology evolves, so does the integration of technology into health care delivery. Telemedicine, the use of information technology to provide remote health care, aims to improve patient access to quality care across a wide range of barriers. Introduction: Our objective was to determine whether teleconsultation leverages specialist expertise at one site within the United States' largest integrated health system. We evaluated the Providence Veterans Affairs Medical Center (PVAMC) teledermatology store-and-forward program. Materials and Methods: We evaluated 460 completed teleconsultations using retrospective chart review at the PVAMC in June-August 2016 for 12 postimaging outcomes, with no exclusion criteria. We determined outcomes using Computerized Patient Record System chart reviews. Results: Dermatologists completed 84-99% of all teleconsultations within 1 week after referral. Fifty one percent (51%) of patients required no dermatology clinic visit. Six percent (6%) of all teleconsultations were ultimately diagnosed with a biopsy-proven skin cancer. Sixty nine percent (69%) of referring providers prescribed recommended medications within 7 days. Discussion: We conclude that the PVAMC teledermatology program enables rapid access to dermatologic expertise while avoiding unnecessary clinic appointments. Conclusion: By detecting both weak links, and steps in the chain of care that successful teledermatology requires, our findings can help teledermatology systems within and outside the Veterans Affairs maximize their effectiveness.
Assuntos
Dermatologia/métodos , Hospitais de Veteranos , Telemedicina/métodos , Adulto , Idoso , Diagnóstico por Imagem , Feminino , Acessibilidade aos Serviços de Saúde , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Rhode Island , Estados Unidos , United States Department of Veterans AffairsAssuntos
Melanoma , Neoplasias Cutâneas , Humanos , Incidência , Sistema de Registros , Programa de SEER , Estados UnidosRESUMO
BACKGROUND: Thin melanomas cause a high death toll despite excellent prognosis. OBJECTIVE: We examined melanoma mortality burden and prognosis by categories of thickness within Surveillance, Epidemiology, and End Results (SEER) 13 Registry 1992-2013. METHODS: We divided 49,319 stage I and II melanoma cases diagnosed between 1992 and 2003 into T1 through T4 and then subdivided T1 into 0.01-0.25 mm, 0.26-0.50 mm, 0.51-0.75 mm, and 0.76-1.00 mm categories. We determined the number and proportion of deaths due to melanoma within 10 years of diagnosis for each thickness category and proportions within T1 subcategories with ulceration. RESULTS: We confirmed prognosis worsened as melanoma thickened from T1 to T4; however, most deaths resulted from melanomas that were diagnosed at the T1 stage. The smallest number of deaths within T1 resulted from 0.01-0.25 mm-thick melanomas; however, the risk for death within 10 years was greater for those diagnosed with melanoma when tumor depth was 0.01-0.25 mm than for those diagnosed when tumor depth was 0.26-0.50 mm. Prognosis worsened with depths starting at 0.51 mm. The pattern within T1 was not explained by ulceration. LIMITATIONS: We did not evaluate melanoma subtype, mitotic rate, or other associated features. CONCLUSION: Thin melanomas are a substantial public health burden. Efforts should be made to diagnose melanoma at the in situ stage.
Assuntos
Melanoma/mortalidade , Melanoma/patologia , Neoplasias Cutâneas/mortalidade , Neoplasias Cutâneas/patologia , Humanos , Melanoma/classificação , Estadiamento de Neoplasias , Prognóstico , Sistema de Registros , Programa de SEER , Neoplasias Cutâneas/classificação , Fatores de TempoRESUMO
BACKGROUND: In order to increase veterans' access to dermatologic care, the Veterans Health Administration (VHA) has developed one of the largest teledermatology programs in the United States. This article describes the recent expansion of the VHA's teledermatology program after local and national initiatives and resource allocation. MATERIALS AND METHODS: This report describes routinely collected VHA data. RESULTS: For the first half of fiscal year 2014, the VHA recorded 31,926 teledermatology encounters, which represents 14% of all recorded teledermatology visits. Although every region in the VHA used teledermatology in the past year, four regions created 51% of the encounters. The use of store-and-forward telehealth (SFT), in which physicians view patient images after the patients were photographed, is increasing, whereas live video use is decreasing. Starting in 2012, encounters for patients in urban areas exceeded those in rural areas. The majority of patients were male veterans 60-79 years of age. Seventy-one percent of SFT consultations for the first half of 2014 were completed within 1 week. CONCLUSIONS: Although errors in and the evolution of coding encounters may distort results, the data show rapid growth of a telemedicine system that increases access to dermatology services for veterans. Most likely this growth reflects institutional commitment to telehealth via policy and resources.
Assuntos
Dermatologia/métodos , Dermatopatias/diagnóstico , Dermatopatias/terapia , Telemedicina/métodos , United States Department of Veterans Affairs , Idoso , Dermatologia/organização & administração , Feminino , Humanos , Masculino , Telemedicina/organização & administração , Estados UnidosRESUMO
Teledermatology makes 3 promises: better, cheaper, and faster dermatologic care. It is "better" because, although it cannot offer as much to the patient as a traditional visit, it extends the dermatologist's reach to places and in ways not previously possible as a result of time and place limitations; it is "cheaper and faster" because it has the potential to reduce costs and increase efficiency for both patients and providers. For teledermatology to fulfill these promises, it must enable dermatologists to improve access by increasing the number of patients evaluated and treated. Increased patient access depends on maximizing a scarce resource-dermatologists' time-in part by avoiding unnecessary and time-consuming face-to-face appointments. We examined the literature to date to determine which teledermatology programs have greater or lesser success in reducing face-to-face visits. Our review highlights 4 factors that are associated with a higher number of face-to-face appointments avoided by teledermatology programs: (1) effective preselection of patients for teleconsultation, (2) high-quality photographic images, (3) dermoscopy if pigmented lesions are evaluated, and (4) effective infrastructure and culture in place to implement teleconsultation recommendations.